B. Riley Securities reiterated coverage on Semler Scientific with a new price target
$SMLR
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
B. Riley Securities reiterated coverage of Semler Scientific with a rating of Buy and set a new price target of $175.00 from $151.00 previously